Sofia Heigis

Sofia Heigis (chief executive) discloses dealings in Oncopeptides AB to Finansinspektionen. The record holds 10 filings, for trades running from 1 December 2021 to 17 March 2026.

The open-market record is one-sided, with 7 purchases worth €57k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €519. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 17 March 2026 with a transaction (€13k) in Oncopeptides AB. The clock since the last published purchase (26 August 2025) now reads 425 days. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.